Levi’s adds to board

Levi Strauss & Co. announced on Tuesday the appointment of David Marberger to its board of directors, as well as the denim maker’s audit committee, effective immediately. 

With more than 30 years of finance and leadership experience, Marberger currently serves as the executive vice president and chief financial officer for Conagra Brands, Inc. 

As CFO of Conagra Brands, Marberger oversees the company’s finances and information technology functions.

Prior to that, Marberger served as chief financial officer at Prestige Brands, a provider of over-the-counter health care products with a portfolio of over 80 brands, as well as also serving as chief financial officer of Godiva Chocolatier for seven years, where he was responsible for the finance, accounting, audit, tax and IT functions, in addition to overseeing Godiva’s worldwide strategic planning process.

Before that, Marberger served as chief financial officer of Tasty Baking Company and spent 10 years at Campbell Soup Company.

“With a distinguished career spanning over three decades, David brings a wealth of experience working with prominent global brands, making him an ideal addition to the LS&Co. board,” said Bob Eckert, chairman of Levi Strauss board of directors.

“David’s expertise will be invaluable as we drive forward the next phase of growth and success for LS&Co., and we’re pleased to welcome him to our board of directors.”

Marberger holds an M.B.A. from The Wharton School, University of Pennsylvania, and a B.B.A. from the University of Massachusetts.

“I am honored to join the board at Levi Strauss & Co., a company I’ve long admired for its rich history and longevity as a globally recognized iconic brand,” said Marberger. “I am eager to work closely with the board of directors and management team to continue driving positive performance and furthering the company’s long-standing legacy.”

The appointment comes just weeks after Levi’s CEO Chip Bergh announced his retirement ​as of April 26, with Michelle Gass, currently president, slated to takeover as CEO of the firm.